Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzodiazepine maintenance treatment in benzodiazepine-dependent patients on opioid agonist therapy (BMX-BAR)
2021-004981-37Phase 4Active
- Sponsor
- Helse Bergen
- Start
- Oct 2021
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oxazepam and diazepam in benzodiazepine dependence and opioid use disorder (OUD) (2 arms), sponsored by Helse Bergen. Primary endpoint: Reduction in illicit benzodiazepine use at end of study. Started Oct 2021; status: active.
02
Drugs
oxazepamdiazepam
03
Conditions
benzodiazepine dependenceopioid use disorder (OUD)
Beyond the preview
Go deeper on 2021-004981-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004981-37.